Report overview
Gene therapy aims to treat disorders by replacing or introducing genes into cells? either inside the body (in vivo) or outside of the body (ex vivo).
This report aims to provide a comprehensive presentation of the global market for Cell and Gene Therapy Manufacturing Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell and Gene Therapy Manufacturing Services. This report contains market size and forecasts of Cell and Gene Therapy Manufacturing Services in global, including the following market information:
Global Cell and Gene Therapy Manufacturing Services Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Cell and Gene Therapy Manufacturing Services market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
By Cell Therapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cell and Gene Therapy Manufacturing Services include Thermo Fisher Scientific, Merck KGaA, Charles River Laboratories, Lonza, Catalent, WuXi AppTec, Takara Bio Inc, Nikon Corporation and FUJIFILM Holdings Corporation, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Wesurveyed the Cell and Gene Therapy Manufacturing Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cell and Gene Therapy Manufacturing Services Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cell and Gene Therapy Manufacturing Services Market Segment Percentages, by Type, 2022 (%)
By Cell Therapy
Allogeneic
Autologous
Viral Vector
By Gene Therapy
Non-viral Vector
Oligonucleotides
Viral Vector
Global Cell and Gene Therapy Manufacturing Services Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cell and Gene Therapy Manufacturing Services Market Segment Percentages, by Application, 2022 (%)
Oncology Diseases
Cardiovascular Diseases
Orthopedic Diseases
Ophthalmology Diseases
Infectious Diseases
Others
Global Cell and Gene Therapy Manufacturing Services Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cell and Gene Therapy Manufacturing Services Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cell and Gene Therapy Manufacturing Services revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cell and Gene Therapy Manufacturing Services revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
Merck KGaA
Charles River Laboratories
Lonza
Catalent
WuXi AppTec
Takara Bio Inc
Nikon Corporation
FUJIFILM Holdings Corporation
F. Hoffmann-La Roche
Oxford Biomedica Plc
Cell and Gene Therapy Catapult
The Discovery Labs LLC
RoslinCT
JRS PHARMA
FinVector
ABL
Resilience
BioCentriq
Porton Biopharma Limited
Andelyn Biosciences
Commercializing Living Therapies
Vibalogics
Anemocyte Srl
ElevateBio
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cell and Gene Therapy Manufacturing Services, market overview.
Chapter 2: Global Cell and Gene Therapy Manufacturing Services market size in revenue.
Chapter 3: Detailed analysis of Cell and Gene Therapy Manufacturing Services company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cell and Gene Therapy Manufacturing Services in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
